Skip to main content

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Project description

Novel drug combination treatment for tuberculosis

Call for proposal

H2020-JTI-IMI2-2018-16-single-stage
See other projects for this call

Coordinator

ACADEMISCH ZIEKENHUIS LEIDEN
Address
Albinusdreef 2
2333 ZA Leiden
Netherlands
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 968 282,50

Participants (8)

UNIVERSITEIT LEIDEN
Netherlands
EU contribution
€ 124 375
Address
Rapenburg 70
2311 EZ Leiden
Activity type
Higher or Secondary Education Establishments
UNIVERSITEIT ANTWERPEN
Belgium
EU contribution
€ 4 179 723,34
Address
Prinsstraat 13
2000 Antwerpen
Activity type
Higher or Secondary Education Establishments
SORBONNE UNIVERSITE
France
EU contribution
€ 343 875
Address
21 Rue De L'ecole De Medecine
75006 Paris
Activity type
Higher or Secondary Education Establishments
MEDIZINISCHE UNIVERSITAET WIEN
Austria
EU contribution
€ 813 125
Address
Spitalgasse 23
1090 Wien
Activity type
Higher or Secondary Education Establishments
KOBENHAVNS UNIVERSITET
Denmark
EU contribution
€ 99 638,53
Address
Norregade 10
1165 Kobenhavn
Activity type
Higher or Secondary Education Establishments
JANSSEN PHARMACEUTICA NV
Belgium
EU contribution
€ 0
Address
Turnhoutseweg 30
2340 Beerse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MITOLOGICS
France
EU contribution
€ 146 630,63
Address
Avenue Gaston Roussel 102
93230 Romainville
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FFUND BV
Netherlands
EU contribution
€ 164 350
Address
Hollandse Kade 32
1391 JM Abcoude
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)